Tipranavir (Aptivus) News, Updated Regularly

New Phase III Study in Previously Untreated HIV Patients Showed - MSN MoneyCentral
October 26, 2008, 7:34 am

In a new Phase III study that compared Merck & Co., Inc.'s HIV integrase inhibitor ISENTRESS ® (raltegravir) to efavirenz [ one of the leading antiretrovirals prescribed for previously untreated (treatment-na ï ve) HIV-infected patients ...

Drugs & Medications - Zegerid Oral - WebMD
October 1, 2008, 12:29 pm

This medication is used to treat acid-related stomach and throat problems (e.g., acid reflux or GERD, ulcers, erosive esophagitis, Zollinger-Ellison Syndrome). It is also used to decrease the risk of stomach bleeding in very ill patients and may be ...

Drugs & Medications - Ticlid Oral - WebMD
September 29, 2008, 1:00 pm

Rarely, this medication has caused serious, sometimes life-threatening blood and immune disorders (agranulocytosis, aplastic anemia, neutropenia, thrombotic thrombocytopenic purpura-TTP). Symptoms may appear within the first few days after starting ...

Medscape Alert Index - Medscape News
August 14, 2008, 6:05 pm

Recalls & Warnings Black-Box Warning Added to Dexedrine Dextroamphetamine sulfate has been linked to sudden death in children being treated for attention deficit-hyperactivity disorder who have structural cardiac abnormalities or other cardiac ...

AIDS and HIV Infection - KVBC
August 13, 2008, 6:06 pm

AIDS stands for Acquired Immune Deficiency Syndrome. AIDS is a serious condition that weakens the body's immune system, leaving it unable to fight off illness. AIDS is the last stage in a progression of diseases resulting from a viral infection known ...

Merck's Antiretroviral Isentress More Efficient In Suppressing HIV - eMaxHealth.com
October 27, 2008, 5:56 pm

Merck's antiretroviral drug Isentress suppresses levels of HIV in previously untreated patients better than the company's antiretroviral efavirenz, according to research presented Sunday at a meeting of the American Society of Microbiology and the ...

New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM ... - PR Newswire
February 7, 2008, 7:20 am

BRIDGEWATER, N.J., Feb. 7 /PRNewswire/ -- New data showed that at 48 weeks, significantly more treatment-experienced adults with HIV-1 with documented resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs ...

Salvage therapy - Aidsmap
July 16, 2006, 7:37 pm

With the recent approval of a fourth class of drugs - fusion inhibitors - and several second generation protease inhibitors, treatment options for people with lengthy experience of anti-HIV drugs - called salvage therapy - are both myriad and ...

FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy - PR Newswire
August 11, 2008, 9:55 am

BRIDGEWATER, N.J., Jan. 21 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has granted accelerated approval to the anti-HIV medication INTELENCE (etravirine) tablets -- the first non-nucleoside reverse transcriptase inhibitor (NNRTI) to ...

Are you looking for additional Aptivus (Tipranavir) news? Try our new "Tipranavir News Focus" area.

Are you looking for additional Aptivus (Tipranavir) information? Try our new "Tipranavir Related Blog Entries" area.

Off-site Tipranavir (Aptivus) Links, User Submitted

The following links have been collected through user bookmark submission in the Tipranavir_Aptivus category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Thu Mar 13

• Aptivus® (tipranavir) Capsules: Official Aptivus Website
• Tipranavir - Yahoo! Health: What are the possible side effects of tipranavir? Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
• Tipranavir - Wikipedia, the free encyclopedia: Tipranavir, or tipranavir disodium, is a nonpeptidic protease inhibitor (PI) manufactured by Boehringer-Ing elheim...
• Tipranavir (marketed as Aptivus): Patient Information Sheet: What is Aptivus? Aptivus is a medicine called a "protease inhibitor" ; that is used to treat adults with Human Immunodeficien cy Virus (HIV). Aptivus blocks HIV protease, an enzyme which is needed for HIV to make more virus. When used with other anti-H
• Tipranavir (Oral Route) - MayoClinic.com: US Brand Names * Aptivus Description Tipranavir is used in combination with ritonavir (e.g., Norvir®), in the treatment of the infection caused...

Thu Apr 26

• Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficien cy Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors
• http://bidocs. boehringer-ing elheim.com/BIW ebAccess/ViewS ervlet.ser?doc Base=renetnt&f olderPath=/Pre scribing+Infor mation/PIs/Apt ivus/10003515+ US+01.pdf

Off-site Tipranavir Research Links

If you still need additional information on Tipranavir then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.